Literature DB >> 24507843

Acute COPD exacerbations.

Jadwiga A Wedzicha1, Richa Singh2, Alex J Mackay2.   

Abstract

Exacerbations are important events for patients with chronic obstructive pulmonary disease (COPD) and key outcomes in COPD studies and trials. Exacerbations have an impact on health status and contribute to disease progression, and exacerbation prevention is a key goal of therapy in COPD. A majority of COPD exacerbations are triggered by respiratory viral infections and/or bacterial infections. Several pharmacologic therapies can prevent COPD exacerbations and reduce hospital admissions. Nonpharmacologic interventions for exacerbation prevention include pulmonary rehabilitation, long-term oxygen therapy, and home noninvasive ventilator support. Improved management of acute exacerbations also prolongs the time to the next exacerbation event.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacterial infections; COPD; Exacerbations; Respiratory viral infections

Mesh:

Substances:

Year:  2014        PMID: 24507843     DOI: 10.1016/j.ccm.2013.11.001

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  50 in total

Review 1.  Updates in Chronic Obstructive Pulmonary Disease for the Year 2014.

Authors:  Sibel Atış Naycı; Lütfi Çöplü; Alev Gürgün; Nurdan Köktürk; Mehmet Polatlı; Elif Şen; Sema Umut; Esra Uzaslan; Nurhayat Yıldırım; Peter J Barnes
Journal:  Turk Thorac J       Date:  2015-04-01

2.  Identifying Patients With COPD at High Risk of Readmission.

Authors:  Jacob E Simmering; Linnea A Polgreen; Alejandro P Comellas; Joseph E Cavanaugh; Philip M Polgreen
Journal:  Chronic Obstr Pulm Dis       Date:  2016-08-29

3.  Suboptimal inhaler medication adherence and incorrect technique are common among chronic obstructive pulmonary disease patients.

Authors:  Krishna B Sriram; Matthew Percival
Journal:  Chron Respir Dis       Date:  2015-09-22       Impact factor: 2.444

Review 4.  Extracorporeal carbon dioxide removal in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Tommaso Pettenuzzo; Eddy Fan; Lorenzo Del Sorbo
Journal:  Ann Transl Med       Date:  2018-01

5.  Detection of salivary aspiration using radionuclide salivagram SPECT/CT in patients with COPD exacerbation: a preliminary study.

Authors:  Peng Hou; Huaifu Deng; Zhida Wu; Haiping Liu; Ni Liu; Zeguang Zheng; Ping Chen
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

6.  Impact of renal dysfunction on in-hospital mortality of patients with severe chronic obstructive pulmonary disease: a single-center Italian study.

Authors:  Fabio Fabbian; Alfredo De Giorgi; Fabio Manfredini; Nicola Lamberti; Silvia Forcellini; Alda Storari; Massimo Gallerani; Gaetano Caramori; Roberto Manfredini
Journal:  Int Urol Nephrol       Date:  2016-03-28       Impact factor: 2.370

Review 7.  Role of Metabolic Reprogramming in Pulmonary Innate Immunity and Its Impact on Lung Diseases.

Authors:  Charalambos Michaeloudes; Pankaj K Bhavsar; Sharon Mumby; Bingling Xu; Christopher Kim Ming Hui; Kian Fan Chung; Ian M Adcock
Journal:  J Innate Immun       Date:  2019-11-29       Impact factor: 7.349

8.  Use of a SmartPhone/Tablet-Based Bidirectional Telemedicine Disease Management Program Facilitates Early Detection and Treatment of COPD Exacerbation Symptoms.

Authors:  Heidi S Smith; Andrew J Criner; Dolores Fehrle; Carla L Grabianowski; Michael R Jacobs; Gerard J Criner
Journal:  Telemed J E Health       Date:  2015-10-09       Impact factor: 3.536

9.  Seasonality, ambient temperatures and hospitalizations for acute exacerbation of COPD: a population-based study in a metropolitan area.

Authors:  Pere Almagro; Carme Hernandez; Pable Martinez-Cambor; Ricard Tresserras; Joan Escarrabill
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-05-08

10.  COPD Is Associated with Elevated IFN-β Production by Bronchial Epithelial Cells Infected with RSV or hMPV.

Authors:  Natasha Collinson; Natale Snape; Kenneth Beagley; Emmanuelle Fantino; Kirsten Spann
Journal:  Viruses       Date:  2021-05-14       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.